X

Telemedicine Appointments Available! 

 Coming soon Retatrutide - Semaglutide 10, 12.5 or 25mg vials  - Tirzepatide 60, 75 or 180mg vials

We will be closed Monday May 27th for Memorial Day 

Blog

TIRZEPATIDE & ITS FINDINGS FOR WEIGHT MANAGEMENT

Read More

Discover Game Changing Weight loss with Retatrutide

An experimental drug from Eli Lilly has the potential to provide greater weight loss benefits than any drug currently on the market. The experimental drug, retatrutide, helped people lose, on average, about 24% of their body weight, the equivalent of about 58 pounds, in a mid-stage clinical trial. This was announced at the American Diabetes Association's annual meeting in San Diego. The findings were also published in The New England Journal of Medicine.

Read More

Heal & Recover Faster with These 3 Peptides

3d glass molecule or atoms on light blue background

Recover faster with peptide therapy! Here are three game-changing peptides shown to help aid in recovery post-injury or surgery.

Read More

Study Shows Tirzepatide Lowers Weight Across All Groups With Obesity

Findings about tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) agonist for the treatment of obesity, were presented at ObesityWeek. The study found consistent weight loss regardless of individual factors such as BMI, age, and various comorbidities. This is exciting news for those searching for medical weight loss options, as tirzepatide has shown promise as a useful treatment.  

Read More